Compare CHE & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CHE | GRFS |
|---|---|---|
| Founded | 1970 | 1940 |
| Country | United States | Spain |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2B | 6.2B |
| IPO Year | N/A | 2006 |
| Metric | CHE | GRFS |
|---|---|---|
| Price | $451.92 | $8.87 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 2 |
| Target Price | ★ $574.25 | $10.15 |
| AVG Volume (30 Days) | 139.1K | ★ 485.7K |
| Earning Date | 02-25-2026 | 07-28-2022 |
| Dividend Yield | 0.53% | ★ 1.60% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 18.95 | 0.64 |
| Revenue | $2,530,634,000.00 | ★ $8,821,017,248.00 |
| Revenue This Year | $5.91 | $5.36 |
| Revenue Next Year | $6.21 | $5.15 |
| P/E Ratio | $23.85 | ★ $17.46 |
| Revenue Growth | 6.45 | ★ 7.31 |
| 52 Week Low | $408.42 | $6.19 |
| 52 Week High | $623.61 | $11.14 |
| Indicator | CHE | GRFS |
|---|---|---|
| Relative Strength Index (RSI) | 59.42 | 44.66 |
| Support Level | $438.87 | $8.79 |
| Resistance Level | $459.55 | $9.40 |
| Average True Range (ATR) | 10.16 | 0.24 |
| MACD | 2.08 | -0.05 |
| Stochastic Oscillator | 77.47 | 12.18 |
Chemed Corp purchases, operates, and divests subsidiaries engaged in diverse business activities to maximize shareholder value. Through its subsidiaries, the company operates in the following segments: VITAS and Roto-Rooter. The VITAS segment generates the majority of the firm's revenue and provides hospice and palliative care services to patients with terminal illnesses through a network of physicians, registered nurses, home health aides, social workers, and volunteers. The Roto-Rooter segment provides plumbing, drain cleaning, water restoration, and related services to residential and commercial customers.
Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.